Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Journal of Medical Microbiology|November 16, 2018
Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnesSae Aoki, Keisuke Nakase, Nobukazu Hayashi, et al.
Anaerobe|November 7, 2016
Emergence of fluoroquinolone-resistant Propionibacterium acnes caused by amino acid substitutions of DNA gyrase but not DNA topoisomerase IVKeisuke Nakase, Yui Sakuma, Hidemasa Nakaminami, et al.
The Journal of Antimicrobial Chemotherapy|July 27, 2020
A novel community-acquired MRSA clone, USA300-LV/J, uniquely evolved in JapanShunsuke Takadama, Hidemasa Nakaminami, Hiroshi Kaneko, et al.
Journal of Global Antimicrobial Resistance|July 13, 2020
Whole-genome sequence of Haemophilus influenzae ST422 outbreak clone strain 2018-Y40 with low quinolone susceptibility isolated from a paediatric patientEmi Tanaka, Takeaki Wajima, Hidemasa Nakaminami, et al.
Biological & Pharmaceutical Bulletin|December 25, 2002
Cloning and characterization of a novel chromosomal drug efflux gene in Staphylococcus aureusKoji Narui, Norihisa Noguchi, Kazunori Wakasugi, et al.
The Journal of Antimicrobial Chemotherapy|February 16, 2008
Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pyloriEmiko Rimbara, Norihisa Noguchi, Takashi Kawai, et al.
Biological & Pharmaceutical Bulletin|September 2, 2011
Characterization of enterococcus strains contained in probiotic productsNorihisa Noguchi, Hidemasa Nakaminami, Keisuke Nakase, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2017
Amino Acid Substitution in the Major Multidrug Efflux Transporter Protein AcrB Contributes to Low Susceptibility to Azithromycin in Haemophilus influenzaeShoji Seyama, Takeaki Wajima, Hidemasa Nakaminami, et al.
The Journal of Antibiotics|June 1, 2023
Avidumicin, a novel cyclic bacteriocin, produced by Cutibacterium avidum shows anti-Cutibacterium acnes activityJuri Koizumi, Keisuke Nakase, Norihisa Noguchi, et al.
The Journal of Dermatology|May 17, 2020
Kampo medicines suppress the production of exfoliative toxins causing impetigo in Staphylococcus aureusIbu Katayama, Hidemasa Nakaminami, Tetsuya Yamada, et al.
Pageof 12